Skip to Main Content

Paper Details

Retrospective Evaluation of First-line Levetiracetam use for Neonatal Seizures after Congenital Heart Defect repair with or without Extracorporeal Membrane Oxygenation.
J Pediatr Pharmacol Ther
0
2022
CHD, Congenital Heart Defect, LEV, Levetiracetam, Neonatal Seizures, anti, fosphenytoin, neonatal congenital heart defect, neonatal seizures, phenobarbital, seizures
Author NameAffiliation
Jennifer C KeeneUniversity of Washington
M WainwrightUniversity of Washington
Lindsey A MorganUniversity of Washington
Ulrike Mietzsch
Ndidi Musa
Xiuhua BozarthUniversity of Washington
Niranjana NatarajanUniversity of Washington
  • 1 - 7

Datasets

Release 1.2